Bellwyck GDUFA Registration

by | Dec 1, 2017 | Pharma News | 0 comments

[vc_row][vc_column extra_css_id=”extra-css-id-5a217ba7b5322″ css=”.vc_custom_1512143859590{padding-right: 100px !important;padding-left: 100px !important;}”][vc_column_text custom_css_uniq_id=”pix-custom-5a217b41488a7″]

Bellwyck is on FDA list of GDUFA Registered Facilities

September 1, 2016 – Bellwyck Pharma Services, a leader in the supply of contract and clinical packaging solutions to the pharmaceutical industry is pleased to announce that it has self-identified with the United States Food and Drug Administration (USFDA) under the Generic Drug User Fee Amendment of 2012 (GDUFA). As required by GDUFA, the company has self-identified as a repackager and is now on FDA’s list of registered facilities for 2016.[/vc_column_text][/vc_column][/vc_row]